Garkaby, Jenny, Willett Pachul, Jessica, Scott, Ori, Abrego Fuentes, Laura, Vong, Linda, Upton, Julia E. M., Kim, Vy H. D., and Roifman, Chaim M.
Patients were included if they had symptoms commensurate with COVID-19 disease and tested positive for COVID-19 (Table 2). Patients with immunodeficiency,[3] primary (PID) or secondary (SID), are considered to be more susceptible than the general population to developing severe COVID-19 diseases, with some studies reporting high rates of hospital ICU admission and mortality especially in patients with Type 1 interferon defects.[4] However, severe COVID-19 risk assessment in this patient population, especially in children, remains inconclusive. Keywords: coronavirus; COVID-19; inborn errors of immunity; infection; pediatric; primary immunodeficiency; SARS-CoV-2 EN coronavirus COVID-19 inborn errors of immunity infection pediatric primary immunodeficiency SARS-CoV-2 1 6 6 03/30/23 20230301 NES 230301 To the Editor, In March 2020, coronavirus disease-2019 (COVID-19) caused by the novel coronavirus SARS-CoV-2 was declared a global pandemic, with an estimated more than half a billion infected individuals and more than six million fatalities. [Extracted from the article]